Momentum Trading Strategy

Notes

Short lessons on momentum trading, every day.

Every note from Substack, in one place: risk, setups, leading stocks, market conditions and the mindset behind them. Search them, browse by topic, or filter by stock.

Showing 1–2 of 2 notes

$CDNA ×
View on Substack ↗

We Spotted CDNA Before the Breakout. Here’s What Happened Next. 👀

We originally found CDNA using MTS Velocity because it had many of the characteristics we look for: big earnings and sales growth, strong margins, strong relative strength, and a leading stock in a leading group.

The price and volume action gave us more reasons to pay attention:

• Higher highs and higher lows.

• Powerful advances on heavy volume.

• Several pullbacks and sideways pauses with tight price action and volume drying up below average.

• Renewed buying as price pushed higher.

After its last earnings surge, CDNA spent time consolidating in a relatively tight range before continuing its advance. The rising 20-day moving average has been a useful guide throughout much of that trend.

This is what we spend our time studying inside MTS: finding strong candidates, preparing before the breakout, and watching how they behave afterward.

It’s also a reminder that finding a winner is only part of the job. You have to give it room to work.

A stock being up from your purchase price is not, by itself, a reason to sell. Follow the price and volume action, respect your sell rules, and avoid cutting a healthy trend short simply because you have a profit.

Cut your losers short. Let your winners run.

Quoting Momentum Trading StrategyWe Didn’t Find CDNA After the Breakout. We Were Watching It Before. 👀 On August 6, I shared a list of medical, pharmaceutical, biotech, and healthcare stocks we were watching inside the MTS Community. CDNA was on it. We originally spotted the stock using the MTS Velocity screener, and the numbers made it difficult…
View on Substack ↗

We Didn’t Find CDNA After the Breakout. We Were Watching It Before. 👀

On August 6, I shared a list of medical, pharmaceutical, biotech, and healthcare stocks we were watching inside the MTS Community.

CDNA was on it.

We originally spotted the stock using the MTS Velocity screener, and the numbers made it difficult to ignore:

• EPS growth: +331%

• Sales growth: +52%

• Pretax margin: 86.8%

• ROE: 29.5%

• Relative Strength: 98

• Industry Group RS: 98

After its earnings run, CDNA pulled back constructively on much lower volume.

Then volume began returning on August 19.

Yesterday, it broke out.

Now it’s continuing higher in pre-market trading. 🚀

While much of the market remained focused on the same AI stocks that had stopped leading, relative strength was pointing toward healthcare and biotech.

Most people notice a stock after the breakout candle appears.

The real work happens before it.

MTS Velocity found the stock. The MTS Trading Room tracked the setup. Price and volume confirmed the opportunity.

Screen. Study. Prepare. Then let the stock prove you right.